Evidence-based child psychiatry and the two solitudes

Evidence-Based Mental Health

Volumn 2, Issue 1, 1999, Pages 6-7

  Szatmari, Peter ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0009702072     PISSN: 13620347     EISSN: None     Source Type: Journal    
DOI: 10.1136/ebmh.2.1.6     Document Type: Editorial

References (9)

1. Usdin TB, Mezey E, Button DC, et al. Gastric inhibitory polypeptide receptor, a member of the secretin-vasoactive intestinal peptide family, is widely distributed in peripheral organs and the brain. Endocrinology 1993;133:2861-70. (Pubitemid 24000747)
2. Goldman LS, Genel M, Brezman RJ, et al. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on scientific affairs, American Medical Association. JAMA 1998;279:1100-7.
3. Bramble DJ. Antidepressant prescription by British child psychiatrists: practice and safety issues. J Am Acad Child Adolesc Psychiatry 1995;34:327-31.
4. Marks A, Fisher M, Lasker S. Adolescent medicine in pediatric practice. J Adolesc Health Care 1990;11:149-53. (Pubitemid 20104595)
5. Aman MG, Van Bourgondien ME, Wolford PL, et al. Psychotropic and anticonvulsant drugs in subjects with autism: prevalence and patterns of use. J Am Acad Child Adolesc Psychiatry 1995;34:1672-81.
6. Hart JT. Cochrane Lecture 1997. What evidence do we need for evidence based medicine? J Epidemiol Community Health 1997;51:623-9.
7. Bastian H. Speaking up for ourselves. The evolution of consumer advocacy in health care. Int J Technol Assess Health Care 1998;14:3-23. (Pubitemid 28099779)
8. Malenka DJ, Baron JA, Johansen S, et al. The framing effect of relative and absolute risk. J Gen Intern Med 1993;8:543-8. (Pubitemid 23312931)
9. Entwistle VA, Watt IS, Davis H, et al. Developing information materials to present the findings of technology assessments to consumers. The experience of the NHS Centre for Reviews and Dissemination. Int J Technol Assess Health Care 1998;14:47-70. (Pubitemid 28099783)